Battles in the War on Cancer: A Wonder Drug on Trial (1) Summary
In part one of a two-part special presentation, NOVA reports on the trials to determine whether the new drug Interleukin-2 - the first to make use of the body's own disease-fighting strategy - will live up to its promise as a pivotal cancer breakthrough. Jane Pauley of NBC News hosts and narrates.
Seen in more than 100 countries, NOVA is the most watched science based television series in the world and the most watched documentary series on PBS. It is also one of television's most acclaimed series, having won many major television awards, most of them many times over.
NOVA - Battles in the War on Cancer: A Wonder Drug on Trial (1) Synopsis and Schedule